Background. In patients with chronic renal failure (CRF), cardiovascular disease is the leading cause of increased morbidity and mortality. We hypothesized a role for endothelial activation and microparticle (MP) numbers and procoagulant activity in the pre-thrombotic state of these patients. Methods. We analysed blood samples of 27 patients with CRF [8 chronic kidney disease Stage 4 (CKD4), 9 peritoneal dialysis (PD) and 10 haemodialysis (HD), samples taken before and after HD] and 10 controls. Degree and nature of endothelial activation were assessed by measuring mature von Willebrand factor (vWF) and vWF propeptide levels. Cellular MPs were characterized by flow cytometry and MP-specific thrombin generation (TG) measurements. Results. CR...
Cardiovascular (CV) death remains the largest cause of mortality in dialysis patients, unexplained b...
Hyperphosphataemia in patients with advanced chronic kidney disease (CKD) is thought to be an import...
Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney diseas...
Background. In patients with chronic renal failure (CRF), cardiovascular disease is the leading caus...
Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle...
Abstract Background Patients with chronic kidney disease (CKD) have a high risk of recurring thrombo...
International audienceBackground: Chronic renal failure patients are at high risk of cardiovascular ...
Background. Traditional cardiovascular risk factors do not explain the high incidence of cardiovascu...
BACKGROUND: Studies in the general population suggest that low-grade inflammation, endothelial dysfu...
Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle...
Background. Microparticles (MPs) are small cell membrane-derived vesicles regarded as both biomarker...
Introduction Patients with chronic kidney disease exhibit features of a hypercoagulable state and...
abstractBackgroundVascular access failure, a major cause of morbidity in hemodialysis (HD) patients,...
Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney diseas...
Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney diseas...
Cardiovascular (CV) death remains the largest cause of mortality in dialysis patients, unexplained b...
Hyperphosphataemia in patients with advanced chronic kidney disease (CKD) is thought to be an import...
Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney diseas...
Background. In patients with chronic renal failure (CRF), cardiovascular disease is the leading caus...
Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle...
Abstract Background Patients with chronic kidney disease (CKD) have a high risk of recurring thrombo...
International audienceBackground: Chronic renal failure patients are at high risk of cardiovascular ...
Background. Traditional cardiovascular risk factors do not explain the high incidence of cardiovascu...
BACKGROUND: Studies in the general population suggest that low-grade inflammation, endothelial dysfu...
Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle...
Background. Microparticles (MPs) are small cell membrane-derived vesicles regarded as both biomarker...
Introduction Patients with chronic kidney disease exhibit features of a hypercoagulable state and...
abstractBackgroundVascular access failure, a major cause of morbidity in hemodialysis (HD) patients,...
Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney diseas...
Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney diseas...
Cardiovascular (CV) death remains the largest cause of mortality in dialysis patients, unexplained b...
Hyperphosphataemia in patients with advanced chronic kidney disease (CKD) is thought to be an import...
Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney diseas...